2 results
Approved WMOCompleted
To validate the use of the Livv Mobiel ECG as a reliable office/bedside screening tool in primary care practice
Approved WMORecruiting
To compare the efficacy of six cycles neoadjuvant PTC plus pertuzumab preceded by either three cycles of FEC-T plus pertuzumab or three cycles of PTC plus pertuzumab in HER2 positive breast cancerSecondary objectives• To describe the safety of the…